• UCLA Health
  • myUCLAhealth
  • School of Medicine
Institute of Urologic Oncology

UCLA Institute of Urologic Oncology

Institute of Urologic Oncology
  • About Us
    • Director's Welcome
    • Board of Directors
    • IUO in the News
    • Why Choose the UCLA IUO
    • Support the IUO
    • Contact Us
    • The Wasserman Building
    • Maps and Directions
    • IUO Membership Information
    • Administrative & Research Staff
    • Positions Available
  • Clinical Programs
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
    • Testicular Cancer
    • Integrated Cancer Program
    • Cancer Genetic Risk Assessment Program
    • Second Opinion for Cancer
  • Research Programs
    • Clinical Trials
    • Faculty Labs
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
    • LuPSMA Risk Calculator
    • PSMA Risk Calculator
    • SPORE In Prostate Cancer
    • Webinars / Videos
  • Clinical Trials
    • What Is a Clinical Trial?
    • Who Should Consider Clinical Trials & Why
    • Bladder Cancer Clinical Trials
    • Kidney Cancer Clinical Trials
    • Prostate Cancer Clinical Trials
    • Testicular Cancer Clinical Trials
    • Clinical Research Team
    • IUO Membership Study Information
  • For Patients
    • Contact Us
    • Clinical Updates
    • Maps and Directions
    • myUCLAhealth
    • Webinars / Videos
  • Fellowship
    • Current Fellows
    • Former Fellows
    • Fellow Testimonials
    • UCLA Health Aerial Tour
    • Webinars/Videos
  • For Healthcare Professionals
    • How to Refer a Patient
    • Lectures & Conferences
    • CTSI Distinguished Speaker Seminar Series
    • DGSOM Research Seminars
    • DGSOM Events
    • JCCC Seminars
    • Researcher Resources
    • SPORE Lectures
  • Expert Team
    • Board of Directors
    • Medical Oncology
    • Nuclear Medicine
    • Pathology
    • Radiation Oncology
    • Radiology
    • Urologic Oncology
    • Research Faculty
    • Emeritus Faculty
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Institute of Urologic Oncology

Clinical Programs

Clinical Programs

Clinical Programs

  • Bladder Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Testicular Cancer
  • Integrated Cancer Program
  • Cancer Genetic Risk Assessment Program
  • Second Opinion for Cancer
  • Bladder Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Testicular Cancer
  • Integrated Cancer Program
  • Cancer Genetic Risk Assessment Program
  • Second Opinion for Cancer
  1. Home
  2. Institute of Urologic Oncology
  3. Clinical Programs
  4. Kidney Cancer

Kidney Cancer

Share this

UCLA Institute of Urologic Oncology (IUO)

Kidney Cancer Program

Program Director: Brian Shuch, MD

Medical Director: Sandy Liu, MD

Being diagnosed with kidney cancer is often the beginning of a stressful and confusing time in a person's life. Obtaining information about the disease and treatment options can often help reduce this stress and aid in the personal decision-making process.

The UCLA Institute of Urologic Oncology (the "IUO") and its multidisciplinary team of world-renown physicians and scientists are working together as a team to personalize patient care and to develop revolutionary treatments for those diagnosed with kidney cancer.

Tweets - UCLA KidneyCancer

#UCLAKidneyCancer - Curated tweets by UCLAHealth

Learn more about our history and accomplishments >

Overview

According to the American Cancer Society, this year approximately 62,700 people in the United States will be diagnosed with kidney cancer and about 14,240 people will die from this disease.  Kidney cancer is among the 10 most common cancers in both men and women, and the risk for developing kidney cancer is higher in men than in women.

Comprehensive Care

As the world’s first, UCLA’s multidisciplinary Kidney Cancer Program has evaluated and treated more than 4,000 patients over 20 years, and offers the latest treatments and compassionate, individualized care.  Patients of the UCLA IUO Kidney Cancer Program have the benefit of our long-held team approach to the treatment and management of kidney cancer that includes world-class urologic oncologists, medical oncologists, radiation oncologists, pathologists, radiologists and our clinical trial's team of physicians and nurses.
Meet our expert team >

Innovative Treatment

The UCLA IUO Kidney Cancer Program offers a variety of innovative treatment options to patients who have been diagnosed with all stages of kidney cancer. By trusting the UCLA Kidney Cancer Program with their care, patients are selecting our team rather than a particular provider. Besides offering minimally invasive and robotic-assisted kidney-sparing surgery like many academic centers, our unique collaborative program allows various members of the team to provide access to state-of-the-art imaging, expert genitourinary pathologists, novel methods of genomic characterization, and emerging medical therapies. UCLA has been a pioneer in the multidisciplinary approach to kidney cancer care. Our treatment portfolio consists of:

  • State-of-the Art surgical techniques, including robotic kidney-sparing and laparoscopic surgery and open surgery.
  • Thermal ablation for small renal tumors, including laparoscopic and percutaneous cryotherapy and radiofrequency ablation.
  • Advanced medical therapies including classic and novel immunotherapy and targeted, biologic therapy.
  • Active surveillance for select small kidney masses.
  • Novel nuclear medicine imaging to aid identification of benign tumors.
  • Expert urologic radiologic imaging including unique contrast-enhanced ultrasound.
  • A comprehensive hereditary kidney cancer program for rare genetic conditions.
  • Genomic tumor profiling to determine what is driving cancer growth.
  • An extensive clinical trial portfolio.

Treatment plans are individualized to each patient’s disease and current state of health. The UCLA IUO Kidney Cancer team has a weekly multi-disciplinary clinic and hold bi-weekly conferences with all team members that provides a forum with diverse, specialized perspectives for deciding upon the best option for each individual patient.

Learn more about how we diagnose and treat kidney cancer >

Pioneering Research

The UCLA Kidney Cancer Program launched in 1989 and has spent the past 30 years leading ground-breaking clinical trials and translational research. UCLA was an early innovator in treatments that bring the patient’s immune system to bear against cancer, stemming from laboratory research. The team has led the development of biomarkers for recurrence after surgery and pushed the envelope for the elective partial nephrectomy.  Defining the role of genetic testing and the characterizing of the genomic mechanisms of sarcomatoid differentiation are recent programmatic highlights.

Clinical Trials

At the UCLA Institute of Urologic Oncology, clinical trials are no longer limited to metastatic cancers or patients who have failed other therapies. Our UCLA IUO doctors are able to provide access to new therapies at earlier stages of the disease. Using our research discoveries in the field of immunotherapy, work is currently under way on a targeted vaccine for kidney cancer that has been in development for the past decade.
Join a kidney cancer clinical trial >

For an appointment with a UCLA kidney cancer specialist, call (310) 794-7700.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest